Evidence map›Paper›PMID 36570123›Full record

ArticleFrontiers in nutrition2022

The influence of early selenium supplementation on trauma patients: A propensity-matched analysis.

Yu-Cheng Chiu, Chia-Ming Liang, Chi-Hsiang Chung, Zhi-Jie Hong, Wu-Chien Chien, Sheng-Der Hsu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yu-Cheng ChiuDivision of General Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Chia-Ming LiangDivision of Trauma Surgery and Critical Care Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Chi-Hsiang ChungDepartment of Medical Research, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Zhi-Jie HongDivision of Trauma Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Wu-Chien ChienSchool of Public Health, National Defense Medical Center, Taipei, Taiwan.
Sheng-Der HsuDivision of Trauma Surgery and Critical Care Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Tri-Service General Hospital · TWNational Defense Medical Center · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Oxidative stress is involved in numerous inflammatory diseases, including trauma. Micronutrients, such as selenium (Se), which contribute to antioxidant defense, exhibit low plasma levels during critical illness. This study aimed to investigate the impact of early Se supplementation on trauma patients. Materials and methods: A total of 6,891 trauma patients were registered at a single medical center from January 2018 to December 2021. Twenty trauma patients with Se supplemented according to the protocol were included in the study group. Subsequently, 1:5 propensity score matching (PSM) analysis was introduced. These patients received 100 mcg three times a day for 5 days. The primary outcome was overall survival (OS); the secondary outcomes were hospital/intensive care unit (ICU) length of stay (LOS), serologic change, ventilator dependence days, and ventilation profile. Results: The hospital LOS (20.0 ± 10.0 vs. 37.4 ± 42.0 days, Conclusion: Early Se supplementation after trauma confers positive results in terms of decreasing overall ICU LOS/hospital LOS and mortality. Organ injury, particularly hepatic insults, and inflammatory status, also recovered better.

Indexed as

length of staypulmonary complicationselenium supplementselenoproteinstrauma

Identifiers

PMID36570123
PMCPMC9773250
OpenAlexW4311864993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.